To investigate this type of CRC, Hilkens and colleagues developed a conditional Rspo3 transgenic mouse (Rspo3inv) where Rspo3 was expressed in cells producing Cre recombinase. This evidence concerns the gene RSPO3 and colorectal carcinoma.